DIAGNOSTIC METHOD FOR PREDICTING RESPONSE TO TNFalpha INHIBITOR
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jul 7, 2016
app pub date -
Oct 18, 2013
filing date -
Oct 18, 2013
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
Disclosed are in vitro diagnostic methods for predicting whether a patient would be responsive to a treatment with a TNFα inhibitor. Said method is based on gene expression profiling. By measuring the expression profile of the disclosed genes it is possible to forecast whether a treatment by a TNFα inhibitor will be successful or not.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully